A 6-month prospective study on efficacy safety and QOL profiles of extended-release formulation of valproate in patients with epilepsy

Seizure

Volumn 20, Issue 1, 2011, Pages 23-26

  Yu, Pei Min ^a   Zhu, Guo Xing ^a   Wu, Xun Yi ^a   Li, Ting ^a   Xu, Lan ^a   Yue, Li ^a   Wang, Bei ^a   Hong, Zhen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Epilepsy; Extended release formulation; Quality of life; Valproate

Indexed keywords

VALPROIC ACID;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; COGNITION; DELAYED DRUG RELEASE; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; EPILEPSY; EXTENDED RELEASE FORMULATION; FEMALE; HUMAN; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SIDE EFFECT; SOCIAL STATUS; VOMITING;

ADOLESCENT; ADULT; AGED; CHEMISTRY, PHARMACEUTICAL; CHILD; DELAYED-ACTION PREPARATIONS; EPILEPSY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 78650804996     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.09.014     Document Type: Article

References (18)

1. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 2002 695 714
2. M. Bialer Extended-release formulations for the treatment of epilepsy CNS Drugs 21 2007 765 774
3. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes Epilepsia 30 1989 389 399
4. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures Epilepsia 22 1981 489 501
5. M.A. Leone, E. Beghi, C. Righini, G. Apolone, and P. Mosconi Epilepsy and quality of life in adults: a review of instruments Epilepsy Res 66 2005 23 44
6. N. Kline Leidy, A.M. Rentz, and E.M. Grace Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy Epilepsia 39 1998 965 977
7. R.M. Pinder, R.N. Brogden, T.M. Speight, and G.S. Avery Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy Drugs 13 1977 81 123
8. A. Richens, D.L.W. Davidson, N.E.F. Cartlidge, and D.J. Easter A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy: the Adult EPITEG Collaborative Group J Neurol Neurosurg 57 1994 682 687
9. R. Davis, D.H. Peters, and D. McTavish Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy Drugs 47 1994 332 372
10. P. Genton, and P. Gelisse Valproic acid: adverse effects R.H. Levy, B.S. Mattson, B.S. Meldrum, Antiepileptic drugs 5th ed. 2002 Lippincott Williams and Wilkins Philadelphia, PA 837 851
11. D. Schmidt Adverse effects of valproate Epilepsia 15 Suppl. 1 1984 S44 S49
12. P.G. Wagner, S.R. Welton, and C.M. Hammond Gastrointestinal adverse effects with divalproex sodium and valproic acid J Clin Psychiatry 61 2000 302 303
13. D. Battino, M.N.G. Dukes, and E. Perucca Anticonvulsants M.N.G. Dukes, J.K. Aronson, Meyler's side effects of drugs 14th ed. 2000 Elsevier Science BV Amsterdam 164 197
14. H. Dinesen, L. Gram, T. Andersen, and M. Dam Weight gain during treatment with valproate Acta Neurol Scand 70 1984 65 69
15. T. Tatsuhara, H. Muro, Y. Matsuda, T. Morita, T. Amisaki, and K. Takeshita Pharmacokinetics of valproic acid and its metabolites after single oral administration of a sustained-release preparation of sodium valproate (KW-6066N) Jpn J Pharmacol Ther 19 1988 749 757
16. E. Kingsley, R. Tweedale, and K.G. Tolman Hepatotoxicity of sodium valproate and other anticonvulsants in rat hepatocyte cultures Epilepsia 21 1980 699 704 (Pubitemid 11092125)
17. T. Kondo, N. Tokinaga, A. Suzuki, S. Ono, H. Yabe, and S. Kaneko Altered pharmacokinetics and metabolism of valproate after replacement of conventional valproate with the slow-release formulation in epileptic patients Pharmacol Toxicol 90 2002 135 138
18. B. Amann, H. Grunze, E. Vieta, and M. Trimble Antiepileptic drugs and mood stability Clin EEG Neurosci 38 2007 116 123